Multi-elemental analysis of serum and amyloid fibrils in familial amyloid polyneuropathy patients

被引:12
|
作者
Susuki, Seiko [1 ]
Ando, Yukio [2 ]
Sato, Takashi [1 ]
Nishiyama, Masami [3 ]
Miyata, Masanori [1 ]
Suico, Mary Ann [1 ]
Shuto, Tsuyoshi [1 ]
Kai, Hirofumi [1 ]
机构
[1] Kumamoto Univ, Dept Mol Med, Grad Sch Pharmaceut Sci, Global COE Cell Fate Regulat Res & Educ Unit, Kumamoto 8620973, Japan
[2] Kumamoto Univ, Grad Sch Med Sci, Dept Diagnost Med, Kumamoto 8600811, Japan
[3] Kumamoto Univ, Inst Resource Dev & Anal, Div Instrumental Anal, Kumamoto 8620973, Japan
来源
关键词
ICP-MS; FAP; amyloid; metals; FAP patients; serum;
D O I
10.1080/13506120802006013
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
There is accumulating evidence of the involvement of biological metal imbalance in the progression of amyloid diseases such as Alzheimer's, Parkinson's and prion diseases. However, the mineral status in patients affected with familial amyloidotic polyneuropathy (FAP) has not been investigated. It is the aim of this study to determine the metal concentrations in the serum and in the transthyretin (TTR) amyloid fibrils of FAP amyloidogenic TTR (ATTR) V30M patients. Multi-elemental analysis of 17 metals by high-resolution inductively coupled plasma mass spectrometry (ICP-MS) revealed a significant decrease of the metals Fe, Cu, Zn, Cs and Ba in the serum of FAP patients (mean age 38.5 +/- 8.3 years; duration of disease 4 +/- 2.6 years) in comparison with that of healthy individuals (mean age 36.2 +/- 9.2 years). On the other hand, these metals, except Cs, were found at high levels in the amyloid fibrils of FAP patients (mean age 55.8 +/- 9.2; duration of disease 6.5 +/- 1.3 years) compared with other metals. These findings firstly suggest that the mineral status could be a candidate factor, which participates in the wide spectrum of clinical pictures of FAP patients.
引用
收藏
页码:108 / 116
页数:9
相关论文
共 50 条
  • [41] Amyloid deposition in the tongue of patients with familial amyloidotic polyneuropathy
    Shinriki, S.
    Ueda, M.
    Yamashit, T.
    Obayashi, K.
    Sun, X.
    Himeno, S.
    Ueda, A.
    Misumi, Y.
    Saito, S.
    Kim, J.
    Meng, W.
    Shinohara, M.
    Ando, Y.
    XIth International Symposium on Amyloidosis, 2008, : 196 - 198
  • [42] A VARIANT OF PRE-ALBUMIN FROM AMYLOID FIBRILS IN FAMILIAL POLYNEUROPATHY OF JEWISH ORIGIN
    PRAS, M
    FRANKLIN, EC
    PRELLI, F
    FRANGIONE, B
    JOURNAL OF EXPERIMENTAL MEDICINE, 1981, 154 (03): : 989 - 993
  • [43] Serum potassium concentrations after suxamethonium in patients with familial amyloid polyneuropathy type I
    Viana, JS
    Neves, S
    Vieira, H
    Bento, C
    Perdigoto, R
    Furtado, AL
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1997, 41 (06) : 750 - 753
  • [44] Distribution of amyloid in the nervous system in transthyretin familial amyloid polyneuropathy
    Said, G
    Plante-Bordeneuve, V
    Lacroix, C
    Adams, D
    NEUROLOGY, 2006, 66 (05) : A86 - A86
  • [45] Patterns of amyloid deposition in salivary gland biopsies of familial amyloid polyneuropathy (FAP) patients
    Domingos, J.
    Coelho, T.
    Moreira, R.
    Melo-Pires, M.
    Taipa, R.
    BRAIN PATHOLOGY, 2014, 24 : 78 - 78
  • [46] Familial amyloid polyneuropathy: Case report
    Debourdeau, E.
    Zagroun, C.
    Daien, V.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2021, 44 (07): : 1084 - 1086
  • [47] FAMILIAL AMYLOID POLYNEUROPATHY - REPORT OF A FAMILY
    GIANGASPERO, F
    SALVI, F
    CECCARELLI, C
    AMBROSETTO, G
    GOVONI, E
    TASSINARI, CA
    CLINICAL NEUROPATHOLOGY, 1985, 4 (03) : 105 - 110
  • [48] Familial amyloid polyneuropathy and liver transplantation
    Monteiro, E
    Freire, A
    Barroso, E
    JOURNAL OF HEPATOLOGY, 2004, 41 (02) : 188 - 194
  • [49] VITREOUS AMYLOIDOSIS IN FAMILIAL AMYLOID POLYNEUROPATHY
    POEPEL, B
    SEIBERTH, V
    KNORZ, MC
    LIESENHOFF, H
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1993, 34 (04) : 992 - 992
  • [50] SCALLOPED PUPILS IN FAMILIAL AMYLOID POLYNEUROPATHY
    RUBINOW, A
    COHEN, AS
    ARTHRITIS AND RHEUMATISM, 1986, 29 (03): : 445 - 447